Cargando…
Genetic Correction of Sickle Cell Anemia and β-Thalassemia: Progress and New Perspective
Gene therapy for β-globinopathies, particularly β-thalassemia and sickle cell anemia, holds promise for the future as a definitive corrective approach for these common and debilitating disorders. Correction of the β-globinopathies using lentivirus vectors carrying the β- or γ-globin genes and elemen...
Autores principales: | Perumbeti, Ajay, Malik, Punam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
TheScientificWorldJOURNAL
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763711/ https://www.ncbi.nlm.nih.gov/pubmed/20419277 http://dx.doi.org/10.1100/tsw.2010.67 |
Ejemplares similares
-
Prevalence and Genetic Analysis of α- and β-Thalassemia and Sickle Cell Anemia in Southwest Iran
por: Nezhad, Forozan H., et al.
Publicado: (2018) -
Side effects of hydroxyurea in patients with Thalassemia major and thalassemia intermedia and sickle cell anemia
por: Ghasemi, A, et al.
Publicado: (2014) -
Thalassemia and sickle cell anemia in Swedish immigrants: Genetic diseases have become global
por: Hemminki, Kari, et al.
Publicado: (2015) -
Prevalence and hematological profile of β-thalassemia and sickle cell anemia in four communities of Surat city
por: Bhukhanvala, Dipal S., et al.
Publicado: (2012) -
Sickle-cell anemia and thalassemia: a primer for health care professionals
Publicado: (1988)